Suchergebnisse - "Docanto, Maria"

PubPharm (36)

1

BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype

enthalten in: EBioMedicine | 2023

von Fettke, H. | Dai, C. | Kwan, E. | +14

2

Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancer

enthalten in: The Prostate | 2021

von Fettke, H. | Kwan, E. | Bukczynska, P. | +11

3

Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer

enthalten in: Prostate cancer and prostatic diseases | 2021

von Lin, H. | Huynh, K. | Kohli, M. | +14

4

Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer

enthalten in: Translational andrology and urology | 2021

von Kwan, E. | Fettke, H. | Crumbaker, M. | +21

5

Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer

enthalten in: European urology focus | 2021

von Kwan, E. | Fettke, H. | Docanto, M. | +15

6

Plasma Cell-Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate Cancer

enthalten in: JCO precision oncology | 2021

von Kwan, E. | Dai, C. | Fettke, H. | +18

7

Independent prognostic impact of plasma NCOA2 alterations in metastatic castration‐resistant prostate cancer

enthalten in: The Prostate | 2021

von Fettke, H. | Kwan, E. | Bukczynska, P. | +11

8

Combined Cell-free DNA and RNA Profiling of the Androgen Receptor : Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer

enthalten in: European urology | 2020

von Fettke, H. | Kwan, E. | Docanto, M. | +17

CommentIn: Eur Urol. 2020 Aug;78(2):181-183. - PMID 32376139

9

Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assay

enthalten in: BioTechniques | 2020

von Fettke, H. | Steen, J. | Kwan, E. | +10

10

Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer

enthalten in: European urology | 2018

von To, S. | Kwan, E. | Fettke, H. | +12

CommentIn: Nat Rev Urol. 2018 Apr;15(4):203. - PMID 29485129